Stay updated on Cabozantinib in Salivary Gland Cancer: Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib in Salivary Gland Cancer: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib in Salivary Gland Cancer: Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.4, replacing v3.5.3, indicating a minor update to the site's versioning. No study content or data appear to be affected.
    Difference
    0.1%
    Check dated 2026-05-15T05:51:52.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    Updates the site’s displayed revision/version identifier from **v3.5.2** to **v3.5.3**.
    Difference
    0.1%
    Check dated 2026-04-24T05:54:16.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Revision updated to v3.5.2 from v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:24:03.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.3 to v3.5.0 on the page. No changes to study content or eligibility criteria were made.
    Difference
    0.1%
    Check dated 2026-03-18T21:58:25.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The page now includes a new revision note: v3.4.3. The previous revision note v3.4.2 was removed.
    Difference
    0.1%
    Check dated 2026-03-11T18:45:34.000Z thumbnail image
  8. Check
    95 days ago
    Change Detected
    Summary
    Revision: v3.4.2 has been added. Notices about government funding and the prior Revision: v3.4.1 have been removed.
    Difference
    0.4%
    Check dated 2026-02-11T09:27:01.000Z thumbnail image

Stay in the know with updates to Cabozantinib in Salivary Gland Cancer: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Salivary Gland Cancer: Clinical Trial page.